Bill

Bill > LD1829


ME LD1829

An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing


summary

Introduced
04/27/2023
In Committee
04/27/2023
Crossed Over
03/27/2024
Passed
03/28/2024
Dead
12/04/2024

Introduced Session

Potential new amendment
131st Legislature

Bill Summary

This bill requires that a state entity, health plan or participating plan qualified under the federal Employee Retirement Income Security Act of 1974 may not purchase prescription drugs to be dispensed or delivered to a consumer of this State at a cost that exceeds the referenced rate. The referenced rate of a prescription drug is the maximum rate for a drug determined by the Secretary of the United States Department of Health and Human Services under the federal Medicare program. Any savings generated as a result must be used to reduce costs to consumers.

AI Summary

This bill requires that a state entity, health plan, or participating plan qualified under the federal Employee Retirement Income Security Act of 1974 (ERISA) cannot purchase prescription drugs for consumers in Maine at a cost that exceeds the maximum rate determined by the Secretary of the United States Department of Health and Human Services under the federal Medicare program (the "referenced rate"). Any savings generated from this requirement must be used to reduce costs for consumers. The bill also prohibits manufacturers or distributors from withdrawing a referenced drug from sale or distribution in Maine to avoid the rate limitations, and it authorizes the Superintendent of Insurance to assess penalties for violations.

Committee Categories

Health and Social Services

Sponsors (11)

Last Action

Died Upon Conclusion of the 131st, Dec 4, 2024 (on 12/04/2024)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...